In Vitro Activity of the Novel Des-F(6)-Quinolone, Garenoxacin, Against 27,831 Community Acquired Respiratory Tract Infection (CARTI) Pathogens: Report from the SENTRY Antimicrobial Surveillance Program
In Vitro Activity of the Novel Des-F(6)-Quinolone, Garenoxacin, Against 27,831 Community Acquired Respiratory Tract Infection (CARTI) Pathogens: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA
